期刊
ACS NANO
卷 15, 期 10, 页码 15741-15753出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.0c09553
关键词
reactive oxygen species; aspirin; mitochondrial dysfunction; efavirenz; darunavir; elvitegravir; coenzyme Q(10)
类别
资金
- Sylvester Comprehensive Cancer Center
- NCI [1P30CA240139]
- Florida International University
- Institute of NeuroImmune Pharmacology
- National Institutes of Health (NIH) [DA044579, DA050528, DA042706, DA040537, DA037838, DA034547]
HIV infection in the brain leads to viral reservoir formation and affects neural protection. Neuroinflammation caused by drug abuse can exacerbate the infection. Current therapies are unable to cross the blood-brain barrier, limiting their effectiveness in treating neural infection.
Human neurotropic immunodeficiency virus (HIV) ingress into the brain and its subsequent replication after infection results in viral reservoirs in the brain. The infected cells include microglia, perivascular macrophages, and astrocytes. HIV-associated neurocognitive disorders (HAND) affect glial cells by activating microglia and macrophages through neuroinflammation, as well as astrocytes through mitochondrial dysfunctions and the onset of oxidative stress, impairing the ability of these cells to engage in neuroprotection. Furthermore, the risk of neuroinflammation associated with HAND is magnified by recreational drug use in HIV-positive individuals. Most of the therapeutic options for HIV cannot be used to tackle the virus in the brain and treat HAND due to the inability of currently available combination antiretroviral therapies (ARTs) and neuroprotectants to cross the blood-brain barrier, even if the barrier is partially compromised by infection. Here, we report a strategy to deliver an optimized antiretroviral therapy combined with antioxidant and anti-inflammatory neuroprotectants using biodegradable brain-targeted polymeric nanoparticles to reduce the burden caused by viral reservoirs in the brain and tackle the oxidative stress and inflammation in astrocytes and microglia. Through in vitro coculture studies in human microglia and astrocytes as well as an in vivo efficacy study in an EcoHIV-infected, methamphetamine-exposed animal model, we established a nanoparticle-based therapeutic strategy with the ability to treat HIV infection in the central nervous system in conditions simulating drug use while providing enhanced protection to astrocytes, microglia, and neurons.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据